Publications (original articles or review articles) published in 2024 from OUS - Department of Urology
10 publications found
The diagnostic yield of the Meares & Stamey test can be significantly improved by symptom-based patient selection and the experience of the test performer
Prostate Cancer Prostatic Dis, 27 (2), 300-304
DOI 10.1038/s41391-024-00824-0, PubMed 38555411
Phytotherapy Might Have a Role in Reducing Unnecessary Prostate Biopsies: Results from an Exploratory, Randomized Controlled Trial of Two Different Phytotherapeutic Agents
Clin Pract, 14 (1), 188-197
DOI 10.3390/clinpract14010016, PubMed 38391402
Computed tomography for visible haematuria - a single nephrographic phase is sufficient for detecting renal cell carcinoma
Scand J Urol, 59, 10-18
DOI 10.2340/sju.v59.18467, PubMed 38226799
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
BJU Int, 133 (6), 717-724
DOI 10.1111/bju.16289, PubMed 38293778
Non-infectious adverse events of transperineal prostate biopsies performed under local anaesthesia
BJU Int, 134 (2), 300-306
DOI 10.1111/bju.16383, PubMed 38679416
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P)
BJU Int, 133 (6), 680-689
DOI 10.1111/bju.16314, PubMed 38469686
Management of the Devastated Bladder Outlet after Prostate CANCER Treatment
Curr Urol Rep, 25 (7), 149-162
DOI 10.1007/s11934-024-01206-8, PubMed 38750347
Reduction of lower urinary tract symptoms in prostate cancer patients treated with robot assisted laparoscopic prostatectomy
Scand J Urol, 59, 121-125
DOI 10.2340/sju.v59.40070, PubMed 38888041
Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience
Eur Urol Open Sci, 65, 13-19
DOI 10.1016/j.euros.2024.05.006, PubMed 38966804
Distinct longitudinal patterns of urine tumor DNA in patients undergoing surveillance for bladder cancer
Mol Oncol (in press)
DOI 10.1002/1878-0261.13639, PubMed 38720532